ANDAORALTABLET
Lifecycle
Pre-Launch
Clinical Trials
20
Clinical Trials (5)
Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)
Started Sep 2014
11 enrolled
HIV Infections
Multiple Dose BE Study With Nevirapine 400mg PR Tablets
Started Aug 2014
46 enrolled
HIV-1
Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir
Started Apr 2014
150 enrolled
HIV
Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice
Started Mar 2012
398 enrolled
HIV Infections
A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
Started Feb 2011
60 enrolled
HIVHIV Infections